Rituximab induction therapy for de novo ANCA associated vasculitis in pregnancy: a case report

Rituximab induction therapy for de novo ANCA associated vasculitis in pregnancy: a case report

Abstract Background The diagnosis of antineutrophil cytoplasmic antibody (ANCA) associated vasculitis (AAV) is rare in pregnancy but potentially life threatening. There are no randomized controlled trials to guide the management of AAV in pregnancy and fetal safety data remains limited. Rituximab ad...

Full description

Bibliographic Details
Main Authors: Claire Harris, Judith Marin, Monica C. Beaulieu
Format: Article
Language:English
Published: BMC 2018-06-01
Series:BMC Nephrology
Subjects:
Antineutrophil cytoplasmic antibody (ANCA)
Pregnancy
Case report
Rituximab
Myeloperoxidase (MPO)
Vasculitis
Online Access:http://link.springer.com/article/10.1186/s12882-018-0949-7

Internet

http://link.springer.com/article/10.1186/s12882-018-0949-7

Similar Items